These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Important therapeutic targets in chronic myelogenous leukemia. Kantarjian HM; Giles F; Quintás-Cardama A; Cortes J Clin Cancer Res; 2007 Feb; 13(4):1089-97. PubMed ID: 17317816 [TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes. Stagno F; Stella S; Spitaleri A; Pennisi MS; Di Raimondo F; Vigneri P Expert Rev Anticancer Ther; 2016; 16(3):273-8. PubMed ID: 26852913 [TBL] [Abstract][Full Text] [Related]
13. [Tyrosine kinase inhibitors for the treatment of CML]. Heim D Ther Umsch; 2006 Apr; 63(4):249-54. PubMed ID: 16689455 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia. Murphy M; Close J; Lottenberg R; Rajasekhar A Am J Med Sci; 2014 Mar; 347(3):254-5. PubMed ID: 24553361 [No Abstract] [Full Text] [Related]
15. Imatinib and regression of type 2 diabetes. Veneri D; Franchini M; Bonora E N Engl J Med; 2005 Mar; 352(10):1049-50. PubMed ID: 15758023 [No Abstract] [Full Text] [Related]
16. [Mechanisms of resistance to BCR-ABL kinase inhibitors]. Diamond J; da Silva MG Acta Med Port; 2013; 26(4):402-8. PubMed ID: 24016650 [TBL] [Abstract][Full Text] [Related]
17. Novel agents in CML therapy: tyrosine kinase inhibitors and beyond. Melo JV; Chuah C Hematology Am Soc Hematol Educ Program; 2008; ():427-35. PubMed ID: 19074121 [TBL] [Abstract][Full Text] [Related]
18. Use of imatinib mesylate in a 15-month old with Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia. Richardson MW; Grewal SS Pediatr Blood Cancer; 2008 Jan; 50(1):186. PubMed ID: 17455313 [No Abstract] [Full Text] [Related]
19. David A. Karnofsky Award lecture. Imatinib as a paradigm of targeted therapies. Druker BJ J Clin Oncol; 2003 Dec; 21(23 Suppl):239s-245s. PubMed ID: 14645403 [No Abstract] [Full Text] [Related]
20. Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic. Eşkazan AE Br J Clin Pharmacol; 2020 Sep; 86(9):1790-1792. PubMed ID: 32383276 [No Abstract] [Full Text] [Related] [Next] [New Search]